A new class of innovative TCR
therapies to treat cancer
About us
Axis is a leading cancer immunotherapy company focused on developing T cell therapies to bring an effective immunotherapy to cancer patients around the world.
Science
Our TCR-T technology is at the forefront of cancer immunotherapies. Our mission is to create effective and safe T cell therapies that target a broad range of cancers.
